Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In Capital	Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Non-controlling Interest	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2021			153,950,895
Beginning balance at Dec. 31, 2021	$ 670,881	$ (75,264)	$ 16	$ 1,691,206	$ (87,946)	$ (1,009,293)	$ 12,682	$ (11,220)	$ 172
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of offering costs (in shares)			27,443,580
Issuance of common stock, net of offering costs	203,796		$ 2	203,794
Exercise of warrants (in shares)			540,541
Exercise of warrants	10,249			10,249
Exercise of stock options (in shares)			349,847
Exercise of stock options	443			443
Delivery of common stock underlying restricted stock units (in shares)			392,326
Stock-based compensation	19,449			19,449
Foreign currency translation adjustment	(2,215)								(2,215)
Net loss attributable to non-controlling interest	(93)							(93)
Net loss attributable to common shareholders	(140,724)					(140,724)
Ending balance at Mar. 31, 2022	$ 686,522		$ 18	1,837,195		(1,137,335)		(11,313)	(2,043)
Ending balance (in shares) at Mar. 31, 2022			182,677,189
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting standards update	Accounting Standards Update 2020-06 [Member]
Beginning balance (in shares) at Dec. 31, 2021			153,950,895
Beginning balance at Dec. 31, 2021	$ 670,881	$ (75,264)	$ 16	1,691,206	$ (87,946)	(1,009,293)	$ 12,682	(11,220)	172
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss attributable to non-controlling interest	(341)
Net loss attributable to common shareholders	(409,496)
Ending balance at Sep. 30, 2022	460,018		$ 19	1,889,274		(1,406,107)		(11,561)	(11,607)
Ending balance (in shares) at Sep. 30, 2022			189,343,531
Beginning balance (in shares) at Mar. 31, 2022			182,677,189
Beginning balance at Mar. 31, 2022	686,522		$ 18	1,837,195		(1,137,335)		(11,313)	(2,043)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of offering costs (in shares)			2,400,000
Issuance of common stock, net of offering costs	16,392		$ 1	16,391
Exercise of stock options (in shares)			80,275
Exercise of stock options	129			129
Delivery of common stock underlying restricted stock units (in shares)			135,603
Stock-based compensation	14,209			14,209
Foreign currency translation adjustment	(844)								(844)
Net loss attributable to non-controlling interest	(150)							(150)
Net loss attributable to common shareholders	(116,124)					(116,124)
Ending balance at Jun. 30, 2022	600,134		$ 19	1,867,924		(1,253,459)		(11,463)	(2,887)
Ending balance (in shares) at Jun. 30, 2022			185,293,067
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of offering costs (in shares)			1,815,351
Issuance of common stock, net of offering costs	8,530		$ 0	8,530
Exercise of stock options (in shares)			134,900
Exercise of stock options	177			177
Delivery of common stock underlying restricted stock units (in shares)			100,213
Issuance of restricted stock (in shares)			2,000,000
Stock-based compensation	12,643			12,643
Foreign currency translation adjustment	(8,720)								(8,720)
Net loss attributable to non-controlling interest	(98)							(98)
Net loss attributable to common shareholders	(152,648)					(152,648)
Ending balance at Sep. 30, 2022	$ 460,018		$ 19	1,889,274		(1,406,107)		(11,561)	(11,607)
Ending balance (in shares) at Sep. 30, 2022			189,343,531
Beginning balance (in shares) at Dec. 31, 2022	209,684,548		209,684,548
Beginning balance at Dec. 31, 2022	$ 401,682		$ 21	1,972,006		(1,558,088)		(11,662)	(595)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of offering costs (in shares)			71,444,729
Issuance of common stock, net of offering costs	106,057		$ 7	106,050
Exercise of stock options (in shares)			28,663
Exercise of stock options	46			46
Cancellation of escrow shares in connection with Edisn acquisition (in shares)			(12,595)
Cancellation of escrow shares in connection with Edisn acquisition	(344)			(344)
Delivery of common stock underlying restricted stock units (in shares)			454,462
Stock-based compensation	11,738			11,738
Molotov non-controlling interest	(499)			(864)				374	(9)
Foreign currency translation adjustment	2,756								2,756
Net loss attributable to non-controlling interest	(11)							(11)
Net loss attributable to common shareholders	(83,613)					(83,613)
Ending balance at Mar. 31, 2023	$ 437,812		$ 28	2,088,632		(1,641,701)		(11,299)	2,152
Ending balance (in shares) at Mar. 31, 2023			281,599,807
Beginning balance (in shares) at Dec. 31, 2022	209,684,548		209,684,548
Beginning balance at Dec. 31, 2022	$ 401,682		$ 21	1,972,006		(1,558,088)		(11,662)	(595)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	273,035
Net loss attributable to non-controlling interest	$ (26)
Net loss attributable to common shareholders	(217,364)
Ending balance at Sep. 30, 2023	$ 333,436		$ 29	2,121,742		(1,775,452)		(11,314)	(1,569)
Ending balance (in shares) at Sep. 30, 2023	292,778,171		292,778,171
Beginning balance (in shares) at Mar. 31, 2023			281,599,807
Beginning balance at Mar. 31, 2023	$ 437,812		$ 28	2,088,632		(1,641,701)		(11,299)	2,152
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of offering costs (in shares)			10,250,000
Issuance of common stock, net of offering costs	10,855		$ 1	10,854
Exercise of stock options (in shares)			161,825
Exercise of stock options	49			49
Delivery of common stock underlying restricted stock units (in shares)			547,493
Stock-based compensation	11,211			11,211
Foreign currency translation adjustment	137								137
Net loss attributable to non-controlling interest	(10)							(10)
Net loss attributable to common shareholders	(49,940)					(49,940)
Ending balance at Jun. 30, 2023	410,114		$ 29	2,110,746		(1,691,641)		(11,309)	2,289
Ending balance (in shares) at Jun. 30, 2023			292,559,125
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of offering costs (in shares)			0
Issuance of common stock, net of offering costs	(9)			(9)
Exercise of stock options (in shares)			82,547
Exercise of stock options	164			164
Delivery of common stock underlying restricted stock units (in shares)			136,499
Stock-based compensation	10,841			10,841
Foreign currency translation adjustment	(3,858)								(3,858)
Net loss attributable to non-controlling interest	(5)							(5)
Net loss attributable to common shareholders	(83,811)					(83,811)
Ending balance at Sep. 30, 2023	$ 333,436		$ 29	$ 2,121,742		$ (1,775,452)		$ (11,314)	$ (1,569)
Ending balance (in shares) at Sep. 30, 2023	292,778,171		292,778,171